Mersana Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need.
Mersana Therapeutics stock last closed at $0.33, down 7.89% from the previous day, and has decreased 89.62% in one year. It has underperformed other stocks in the Biotechnology industry by 0.12 percentage points. Mersana Therapeutics stock is currently +26.25% from its 52-week low of $0.26, and -90.99% from its 52-week high of $3.63.
As of Apr 21, 2025, there are 124.63M MRSN shares outstanding. The market value of MRSN is $40.75M. In the past 24 hours, 2.33M MRSN shares were traded.
How to Buy Mersana Therapeutics Stock
Wondering how to invest in Mersana Therapeutics stock? Here's how.
Figure out where to buy Mersana Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Mersana Therapeutics stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Choose your method of payment and add your info.
Research Mersana Therapeutics stock: The Mersana Therapeutics ticker symbol is MRSN. Is Mersana Therapeutics stock a good investment? Should you buy shares of MRSN? How do MRSN's underlying business fundamentals look? Do top analysts think Mersana Therapeutics is a good buy? Why has MRSN's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if MRSN is a good stock to buy).
Make your MRSN buy order: Decide if you will purchase MRSN shares at the current market price or use a limit order to buy MRSN stock at a specific price.
Get the latest news on your MRSN position: Create a watchlist to monitor your position in Mersana Therapeutics stock.
Step 1: Figure out where to buy Mersana Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy MRSN shares.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you are able to buy MRSN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Mersana Therapeutics stock
Once you have chosen the best place to buy Mersana Therapeutics stock, it's important to evaluate their stock before you invest, so you can understand the risk as well as the upside.
Mersana Therapeutics Numbers
MRSN Price
$0.33
1w %
-1.21%
1y %
-89.62%
5y %
-96.15%
P/E
-0.58x
P/B
-4.29x
P/S
0.99x
PEG
N/A
Revenue
$40.50M
Earnings
-$69.19M
Fore. Rev. Growth
38.9%
Fore. Earn. Growth
N/A
Market Cap
$40.75M
Next Earnings
May 7, 2025
Next Dividend
N/A
MRSN Due Diligence Checks
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
Last year, MRSN revenue was $40.50M. In the last five year, MRSN's revenue has increased by -0.78% per year. This was slower than the Biotechnology industry average of 44.31%.
No, Mersana Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about MRSN?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your MRSN buy order
There are two main types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly fine for most investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you need additional help buying stocks on eToro, click the how to video below:
How much does it cost to buy one Mersana Therapeutics share?
As of Apr 21, 2025, it costs $0.33 to buy one share of Mersana Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.16, you can buy 0.5 shares of MRSN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.